Signal active
Organization
Contact Information
Overview
Arda Therapeutics is a biotechnology company taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions. Their approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. They then design therapies to eliminate these - and only these - cells.
Arda was founded in 2021 in the San Francisco Bay Area, CA.
About
Biotechnology, Health Care, Therapeutics
2021
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Arda Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $204.0M in funding across 24 round(s). With a team of 1-10 employees, Arda Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Arda Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
2
2
0
$8.5M
Details
1
Arda Therapeutics has raised a total of $8.5M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed |
Investors
Arda Therapeutics is funded by 3 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Konstantin von Unger | - | FUNDING ROUND - Konstantin von Unger | undefined |
Arda Therapeutics | - | FUNDING ROUND - Arda Therapeutics | undefined |
Leblon Capital | - | FUNDING ROUND - Leblon Capital | undefined |
Recent Activity
There is no recent news or activity for this profile.